Cancer Immunotherapy-revisited, Nat. Rev. Drug Discovery, vol.10, 2011. ,
Cancer Immunotherapy: Breaking the Barriers to Harvest the Crop, Nat. Med, vol.10, pp.887-892, 2004. ,
Oncology Meets Immunology: The Cancer-Immunity Cycle, Immunity, pp.39-40, 2013. ,
Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response, Nat. Rev. Immunol, vol.12, pp.269-281, 2012. ,
Adoptive Cell Transfer as Personalized Immunotherapy for Human Cancer, vol.348, pp.62-68, 2015. ,
Engineered T Cells: The Promise and Challenges of Cancer Immunotherapy, Nat. Rev. Cancer, vol.16, pp.566-581, 2016. ,
Cancer Immunotherapy: The Beginning of the End of Cancer, BMC Med, vol.14, p.73, 2016. ,
Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-Debakey Clinical Medical Research Award, JAMA, J. Am. Med. Assoc, vol.314, pp.1113-1114, 2015. ,
Novel Cancer Immunotherapy Agents With Survival Benefit: Recent Successes and Next Steps, Nat. Rev. Cancer, vol.11, pp.805-812, 2011. ,
Towards Personalized, TumourSpecific, Therapeutic Vaccines for Cancer, Nat. Rev. Immunol, vol.18, pp.168-182, 2017. ,
Cancer Vaccines: Always a Bridesmaid, Never a Bride, J. Natl. Cancer Inst, vol.105, pp.248-249, 2013. ,
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond, Clin. Cancer Res, vol.22, 1897. ,
Sipuleucel-T for the Treatment of Prostate Cancer: Novel Insights and Future Directions, Future Oncol, vol.14, pp.907-917, 2018. ,
Targeting the Heterogeneity of Cancer With Individualized Neoepitope Vaccines, Clin. Cancer Res, vol.22, pp.1885-1896, 2016. ,
Emerging Opportunities and Challenges in Cancer Immunotherapy, Clin. Cancer Res, vol.22, pp.1845-1855, 2016. ,
Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations, Methods Mol. Biol, pp.11-26, 1331. ,
DOI : 10.1007/978-1-4939-2874-3_2
Chemical Biology Approaches to Designing Defined Carbohydrate Vaccines, Chem. Biol, vol.21, pp.38-50, 2014. ,
DOI : 10.1016/j.chembiol.2014.01.002
URL : https://doi.org/10.1016/j.chembiol.2014.01.002
, Expert Rev. Vaccines, vol.2, pp.633-648, 2003.
Glycoprotein Conjugate Vaccines. Vaccine, vol.17, pp.28-36, 1999. ,
DOI : 10.1016/s0264-410x(99)00232-7
Carbohydrate-Based Vaccines: Challenges and Opportunities, Expert Rev. Vaccines, vol.9, pp.1257-1274, 2010. ,
DOI : 10.1586/erv.10.120
,
Improvement of the Immune Efficacy of Carbohydrate Vaccines By Chemical Modification on the GM3 Antigen, Org. Biomol. Chem, vol.13, pp.6399-6406, 2015. ,
Sle (a), Ca19?9) and Construction of an Immunogenic Sle(a) Vaccine, Synthesis of Sialyl Lewis(a), vol.58, pp.1397-1405, 2009. ,
, Tn Immunotherapy Avoiding Immune Deviation. Int. J. Immunopathol. Pharmacol, vol.29, pp.812-817, 2016.
Altered Glycosylation of Proteins in Cancer: What is the Potential for New Anti-Tumour Strategies, Anti-Cancer Agents Med. Chem, 2008. ,
Glycans in Cancer and Inflammation-potential for Therapeutics and Diagnostics, Nat. Rev. Drug Discovery, vol.4, pp.477-488, 2005. ,
Altered Glycosylation of Proteins Produced By Malignant Cells, and Application for the Diagnosis and Immunotherapy of Tumours, Immunol. Cell Biol, vol.83, pp.429-439, 2005. ,
Perspectives on the Significance of Altered Glycosylation of Glycoproteins in Cancer, Glycoconjugate J, vol.14, pp.569-576, 1997. ,
Aiming At the Sweet Side of Cancer: Aberrant Glycosylation as Possible Target for Personalized-Medicine, Cancer Lett, vol.352, pp.102-112, 2014. ,
Chemical Diversity in the Sialic Acids and Related Alpha-Keto Acids: An Evolutionary Perspective, Chem. Rev, vol.102, pp.439-469, 2002. ,
A Mutation in Human Cmp-Sialic Acid Hydroxylase Occurred After the Homo-Pan Divergence, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.11751-11756, 1998. ,
Human Uptake and Incorporation of an Immunogenic Nonhuman Dietary Sialic Acid, Proc. Natl. Acad. Sci. U. S. A, vol.100, 2003. ,
Mechanism of Uptake and Incorporation of the Non-Human Sialic Acid NGlycolylneuraminic Acid Into Human Cells, J. Biol. Chem, vol.280, pp.4228-4237, 2005. ,
, Abundance, and Composition of Anti-Neu5Gc Antibodies in Normal Humans: Potential Implications for Disease, vol.18, pp.818-830, 2008.
, Human XenoAutoantibodies Against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer. Cancer Res, vol.71, pp.3352-3363, 2011.
Inverse Hormesis of Cancer Growth Mediated By Narrow Ranges of Tumor-Directed Antibodies, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.5998-6003, 2014. ,
Cell MembraneDerived Nanomaterials for Biomedical Applications, Biomaterials, vol.128, pp.69-83, 2017. ,
Enhanced Blood Suspensibility and Laser-Activated Tumor-Specific Drug Release of Theranostic Mesoporous Silica Nanoparticles By Functionalizing With Erythrocyte Membranes, vol.7, pp.523-537, 2017. ,
Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors, Theranostics, vol.6, pp.1004-1011, 2016. ,
Delivery of Drugs Bound to Erythrocytes: New Avenues for an Old Intravascular Carrier, Ther. Delivery, vol.6, pp.795-826, 2015. ,
The Organization of Proteins in the Human Red Blood Cell Membrane. A Review, J. Cell Biol, vol.62, 1974. ,
The Glycocalyx Protects ErythrocyteBound Tissue-Type Plasminogen Activator From Enzymatic Inhibition, J. Pharmacol. Exp. Ther, vol.321, pp.158-164, 2007. ,
Discovery of the Natural Anti-Gal Antibody and Its Past and Future Relevance to Medicine, Xenotransplantation, vol.20, pp.138-147, 2013. ,
Alpha-Gal Inactivated Heart Valve Bioprostheses Exhibit an Anti-Calcification Propensity Similar to Knockout Tissues, Tissue Eng., Part A, vol.23, pp.1181-1195, 2017. ,
Neu5Gc and ?1?3 GAL Xenoantigen Knockout Does Not Affect Glycemia Homeostasis and Insulin Secretion in Pigs, vol.66, pp.987-993, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02156128
Profiling Anti-Neu5Gc IgG in Human Sera With a Sialoglycan Microarray Assay, 2017. ,
Sensitive and Specific Detection of the Non-Human Sialic Acid N-Glycolylneuraminic Acid in Human Tissues and Biotherapeutic Products, J. Biol. Chem, vol.4, issue.e4241, 2009. ,
, Vaccine Immunology. Vaccines, vol.5, pp.17-36, 2008.
Applications and Optimization of Immunization Procedures, ILAR J, vol.46, pp.241-257, 2005. ,
Hormesis in Cancer Immunology: Does the Quantity of an Immune Reactant Matter? Oncoimmunology, vol.3, 2014. ,
Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid, vol.18, pp.1155-1171, 2017. ,
Evidence for a Human-Specific Mechanism for Diet and AntibodyMediated Inflammation in Carcinoma Progression, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.18936-18941, 2008. ,
A Red Meat-Derived Glycan Promotes Inflammation and Cancer Progression, Proc. Natl. Acad. Sci. U. S. A, vol.112, pp.542-547, 2015. ,
Polyclonal Human Antibodies Against Glycans Bearing Red MeatDerived Non-Human Sialic Acid N-Glycolylneuraminic Acid Are Stable, Reproducible, Complex and Vary Between Individuals: Total Antibody Levels Are Associated With Colorectal Cancer Risk, PLoS One, vol.13, 2018. ,
Glycan Microarray Reveal Induced Iggs Repertoire Shift Against a Dietary Carbohydrate in Response to Rabbit Anti-Human Thymocyte Therapy, Oncotarget, vol.8, pp.112236-112244, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01885572
Hypoxic Culture Induces Expression of Sialin, a Sialic Acid Transporter, and CancerAssociated Gangliosides Containing Non-Human Sialic Acid on Human Cancer Cells, Cancer Res, vol.66, 2006. ,
Antibody Therapy of Cancer, Nat. Rev. Cancer, vol.12, pp.278-287, 2012. ,
Heterogeneity in Vaccine Immune Response: The Role of Immunogenetics and the Emerging Field of Vaccinomics, Clin. Pharmacol. Ther, vol.12, issue.59, pp.653-664, 2007. ,
No. e2006601. (61) Ye, Z.; Qian, Q.; Jin, H.; Qian, Q. Cancer Vaccine: Learning Lessons From Immune Checkpoint Inhibitors, PLoS Biol, vol.16, pp.263-268, 2018. ,
Vaccines for Tumour Prevention, Nat. Rev. Cancer, vol.6, pp.204-216, 2006. ,
Personalized T Cell-Mediated Cancer Immunotherapy: Progress and Challenges, Curr. Opin. Biotechnol, vol.48, pp.142-152, 2017. ,
DOI : 10.1016/j.copbio.2017.03.024
URL : https://doi.org/10.1016/j.copbio.2017.03.024
Human Tumor Antigens Yesterday, Today, and Tomorrow, Cancer Immunol. Res, vol.5, pp.347-354, 2017. ,
DOI : 10.1158/2326-6066.cir-17-0112
URL : http://cancerimmunolres.aacrjournals.org/content/canimm/5/5/347.full.pdf
Glycan Microarray Reveal the Sweet Side of Cancer Vaccines, Cell Chem. Biol, vol.23, pp.1446-1447, 2016. ,
Glycans in Immune Recognition and Response, Carbohydr. Res, vol.389, pp.115-122, 2014. ,
Involvement of a Non-Human Sialic Acid in Human Cancer, Front. Oncol, vol.4, p.33, 2014. ,
Blood Cells as an Antigen-Delivery System, Biotechnol. Appl. Biochem, vol.16, pp.188-194, 1992. ,
Tumor Growth Control Using Red Blood Cells as the Antigen Delivery System and Poly(I:C), J. Immunother, vol.35, pp.409-417, 2012. ,
Situ Targeting of Dendritic Cells By Antigen-Loaded Red Blood Cells: A Novel Approach to Cancer Immunotherapy, Vaccine, vol.28, 2010. ,
Immunoreactive T and Tn Epitopes in Cancer Diagnosis, Prognosis, and Immunotherapy, J. Mol. Med, vol.75, pp.594-602, 1997. ,
Drug Delivery By Red Blood Cells: Vascular Carriers Designed By Mother Nature, Expert Opin. Drug Delivery, vol.7, pp.403-427, 2010. ,
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance, vol.11, pp.6225-6236, 2015. ,
Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins, Cell Chem. Biol, vol.23, pp.1515-1525, 2016. ,
Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate Against, ACS Cent. Sci, vol.4, pp.357-361, 2018. ,
Arrays: From Basic Biochemical Research to Bioanalytical and Biomedical Applications, Annu. Rev. Anal. Chem, vol.9, pp.223-247, 2016. ,
Vaccine Protocols Optimization: In Silico Experiences, Biotechnol. Adv, vol.28, pp.82-93, 2010. ,
Vaccination With High-Affinity Epitopes Impairs Antitumor Efficacy By Increasing PD-1 Expression on CD8, Cancer Immunol. Res, vol.5, pp.630-641, 2017. ,
Cancer Vaccines, BMJ, vol.350, p.988, 2015. ,
The Genetic Background Influences the Cellular and Humoral Immune Responses to Vaccines, Clin. Exp. Immunol, vol.186, pp.190-204, 2016. ,
Synergistic Effects of L-and P-Selectin in Facilitating Tumor Metastasis Can Involve Non-Mucin Ligands and Implicate Leukocytes as Enhancers of Metastasis, Proc. Natl. Acad. Sci. U. S. A, vol.99, 2002. ,